Full name
The Evaluation Of Use of Belimumab in Routine Care SEttings in Lupus Nephritis (LN): the OBSErve-LN Study
NCT Number
NCT06527872
Geography
US
Locations
United States
Primary Endpoints
Number of participants maintaining renal function (less than equal to [<=]30 percentage [%] decline in estimated glomerular filtration rate [eGFR] from the initiation of belimumab) and not requiring renal replacement therapy, at Month 24
Order
0
Disease
Version
Phase
Observational
Status
Recruiting